C ontinuous improvement of peritoneal dialysis
(PD) technique has resulted in a remarkable reduction of peritonitis rates. Increased microbiological safety during fluid instillation by introducing a double-bag disconnect system was a cornerstone of this development (1, 2) . This innovation opened the door for improvement of technique survival in PD since, in many reports, transfer of patients to hemodialysis was directly related to the infectious complications of this method (3) (4) (5) (6) (7) (8) (9) . With the PD population showing improving survival rates, attention is now increasingly focused on the issues of biocompatibility of peritoneal dialysis fluids (PDF) (10) (11) (12) (13) (14) (15) (16) . The development of more-biocompatible PDF, thereby exerting fewer inhibitory effects on peritoneal host defense mechanisms, may help to further reduce peritonitis incidence rates. More importantly, these fluids also offer a potential benefit for better preservation of the peritoneum, both its structure and its function (17) . During time on PD, the peritoneal membrane is under constant stress by exposure to standard, hyperosmolar acidic PDF, which additionally contain high concentrations of glucose degradation products (GDP). This effect becomes especially important during long-term PD, when the treatment modality may become limited by structural and functional deterioration of the membrane, resulting either from repeated peritonitis episodes or from long-term exposure to PDF (18, 19) .
In vitro studies have demonstrated significant differences in biocompatibility profiles of fluids developed for PD (20) (21) (22) (23) (24) . In this respect, the low pH and high lactate concentration of PDF, their high osmolarity related to glucose content, and the presence of GDP have all been indicated as factors responsible for the observed inhibition of peritoneal cell functions (25) (26) (27) . It remains less clear, however, whether the long-term use of the bioincompatible dialysis fluids has a significant deleterious effect on the structure, function, and longevity of the peritoneum as the dialysis membrane (6, 28, 29) .
These studies gave rationale to the development of potentially more-biocompatible PDF, where lactate buffer is, in part or completely, replaced by bicarbonate as a physiological buffer system and that contain very low concentrations of GDP (30) (31) (32) (33) . Additionally, bicarbonate-buffered, pH-neutral PDF aids the correction of systemic metabolic acidosis related to chronic renal failure, thereby positively influencing muscle protein and bone metabolism (34, 35) .
In the peritoneal cavity, the instilled peritoneal fluid equilibrates rapidly with body fluids, with fast and significant change of dialysate pH and lactate concentration, and slower decrease of glucose concentration and osmolarity (24, 36) . This finding has put into considerable doubt the clinical relevance of phenomena observed in vitro, and has led to the development of a new experimental approach to evaluating the effect of PD solutions on host defense parameters, where peritoneal cells are exposed in vivo to the tested solution, collected from the dialysate, and their specific functions are tested in vitro (37) (38) (39) (40) .
In order to evaluate the biocompatibility profile of the newly designed dialysis solutions, an acute study was performed where function of peritoneal leukocytes after in vivo exposure to the test dialysis solutions was examined. Cell function was assessed after overnight intraperitoneal exposure to different PDF and the ability of the exposed cells to produce proinflammatory cytokines was measured by specific ELISA.
PATIENTS AND METHODS

PATIENTS
The study was performed on 8 patients (6 males, 2 females) with end-stage renal disease treated with continuous ambulatory peritoneal dialysis (CAPD) in the Department of Nephrology of the Medical University of Gdansk, Poland. They were stable, long-term dialysis patients using the Fresenius ANDY-Plus dialysis system (Fresenius Medical Care, Bad Homburg, Germany). Patients with diabetes were excluded from the study. None of the patients used steroids or nonsteroidal anti-inflammatory drugs in anti-inflammatory doses. All patients had been treated with CAPD for at least 3 months prior to inclusion. No peritonitis or any other systemic or local infection was observed during the study period. Written informed consent was received from each participating patient and the protocol was accepted prior to start by the Ethics Committee of the Medical University of Gdansk. Data for patients included in the study are shown in Table 1 .
STUDY DESIGN AND TEST SOLUTIONS
The ex vivo study was performed in all patients in an open crossover fashion, with all PDF being evaluated in each patient. The overnight dwells with test solutions were performed at weekly intervals, with patients using their usual CAPD prescription between dwells with test fluids. Each patient performed, in total, three test dwells containing 34 mmol/L bicarbonate (Bic-PDF), 39 mmol/L bicarbonate (Bic Hi-PDF), or 35 mmol/L lactate (Lac-PDF), with each fluid being evaluated once in each patient. During the 24 hours before the test dwell, only 1.5% glucose fluid was allowed. All bicarbonate-containing fluids were packed in double-chamber, gas-tight bags and their contents were mixed immediately before infusion. The standard Lac-PDF served as a control fluid. The test solutions are described in Table 2 .
PROTOCOL FOR EX VIVO EXPOSURE AND CELL ISOLATION
For the ex vivo studies, test PDF were infused into the peritoneal cavity and allowed to dwell overnight for exactly 8 hours. Immediately after drainage, the fluid was ice-cooled and peritoneal leukocytes subsequently isolated by gentle centrifugation (3500 rpm, 35 minutes, 10°C) of 1200 -2200 mL of the effluent. Cell pellets were washed twice with phosphate-buffered saline (PBS; Biomed, Lublin, Poland) and the number of cells was evaluated in an automatic cell counter (Cell-Dyn 4000; Abbott Diagnostics, Abbott Park, Illinois, USA). The cells were resuspended in 50% human serum in RPMI 1640 (Roswell Park Memorial Institute medium formulation; Biomed) to cell density 1 × 10 7 /mL. Two cytospin preparations of each effluent sample were prepared, fixed, and stained for assessment of the cell populations present. Cell differential counts of peritoneal effluents were performed by an independent pathologist in a blinded manner.
TUMOR NECROSIS FACTOR (TNF)-α AND INTERLEUKIN (IL)-6 SECRETION BY PERITONEAL MACROPHAGES (PMΦ)
Cytokine secretion (control and stimulated) from cells isolated from peritoneal effluent was assessed directly using the modified ELISA system (Biosource Europe, Nivelles, Belgium). Escherichia coli lipopolysaccharide (LPS) in concentrations ranging from 1 to 100 ng/mL was used to stimulate TNFα secretion; LPS concentrations of 10 and 100 ng/mL and Staphylococcus aureus derivate protein A (10 μg/mL) (Sigma-Aldrich, Poznan, Poland) were used to stimulate IL-6 production. Briefly, 200 μL culture medium (RPMI) was added to anti-TNFα-or anti-IL-6-coated wells for standards and control samples to be run without stimulant, and 200 μL RPMI with appropriate stimulant was added to the sample wells. Standards (25 μL) or peritoneal cell suspension (0.25 × 10 6 cells) was added to the standard wells or to the sample wells, respectively. The plates were incubated at 37°C for 2 hours for TNFα and for 3 hours for IL-6 secretion. Incubation was terminated by washing the plates. The amount of generated cytokine bound to the antibody-precoated plate was measured with standard ELISA according to the manufacturer's protocol. In the initial experiments, the number of peritoneal leukocytes necessary for incubation in each well was determined in order to establish a concentration of cytokines within the range of the standard curve of the assay. All measurements were performed in duplicate wells. The plates were read at 450 nm (reference filter 630 nm) in an ELISA spectrophotometer (Stat fax 2100; Awareness Technology, Palm City, Florida, USA). The standard curve was constructed for each run and the concentration of cytokines in samples and controls was determined from the absorbance. Data are expressed as amount of cytokine normalized to the number of PMΦ used in the experiment, as calculated from the cytospin preparation.
SPENT DIALYSATE MEASUREMENTS
In all overnight dialysates of the test dwells, sodium, potassium, ionized and total calcium, and glucose were measured using routine laboratory methods (Hitachi 704 multi-analyzer, Boehringer Mannheim, Mannheim, Germany). During drainage, samples were drawn into sealed syringes and measured immediately with a blood gas analyzer (Ciba Corning Diagnostics, Halstead, UK).
STATISTICAL ANALYSIS
Statistical analysis was performed using one-way repeated measures analysis of variance (ANOVA) with Statistica licensed software (Statsoft, Tulsa, Oklahoma, USA). Tukey's test was used for the post hoc analysis where appropriate. Data are presented as mean ± standard deviation. A p value of less than 0.05 represents statistical significance.
R E S U L T S PERITONEAL CELL OUTPUT AND ULTRAFILTRATION
An 8-hour overnight dwell resulted in the recovery of a sufficient number of peritoneal cells, ranging from 7 per overnight fluid drainage, from all patients. Significant differences in cell counts were not recorded between PDF. As revealed from cytospin preparations, percentages of PMΦ among other peritoneal cells ranged from 70% to 92%. Average percentage of PMΦ was 84.3% ± 7.0%, 80.9% ± 6.2%, and 78.5% ± 13.2% in Lac-PDF, Bic-PDF, and Bic Hi-PDF effluents, respectively. These differences were not significant (p = 0.28). There were no significant differences between overnight ultrafiltration generated by lactate and bicarbonate solutions (1975 ± 328 mL, 2013 ± 304 mL, and 2088 ± 148 mL with Lac-PDF, Bic-PDF, and Bic Hi-PDF, respectively, p = 0.79).
CYTOKINE SECRETION
TNFα and IL-6 generation is expressed as the amount of cytokine produced per 10 6 PMΦ used in the experiments, as calculated from the percentage in cytospin preparations. The constitutive TNFα generation by PMΦ during the 2-hour incubation was 242 ± 279, 361 ± 381, and 357 ± 329 pg/10 6 PMΦ following an 8-hour dwell in Lac-PDF, Bic-PDF, and Bic Hi-PDF, respectively. Under the same conditions, the unstimulated IL-6 synthesis during the 3-hour incubation was 157 ± 105, 215 ± 161, and 252 ± 164 pg/10 6 PMΦ following dwells with tested solutions. The observed differences between cytokine secretions from peritoneal cells pretreated in different fluids were not statistically significant (p = 0.73 for TNFα, p = 0.36 for IL-6) (Figures 1 and 2) .
Stimulation of PMΦ with LPS resulted in a dosedependent significant increase in cytokine secretion for both TNFα and IL-6. Stimulation of PMΦ with 100 ng/mL LPS resulted, on average, in an 8-to 10-fold increase in both TNFα and IL-6 production compared to unstimulated cells. No significant differences in stimulated TNFα and IL-6 synthesis following in vivo exposure to Lac-PDF, Bic-PDF, and Bic Hi-PDF were observed. TNFα generation with stimulation by 100 ng/mL LPS reached 2865 ± 1216, 2910 ± 1102, and 3292 ± 558 pg/10 6 PMΦ after dwells with Lac-PDF, Bic-PDF, and Bic Hi-PDF, respectively (p = 0.54). Interleukin-6 production by stimulation with 100 ng/mL LPS was 891 ± 335, 1380 ± 1149, and 1442 ± 966 pg/10 6 PMΦ for Lac-PDF, Bic-PDF, and Bic Hi-PDF, and 197 ± 124, 376 ± 385, and 471 ± 311 pg/10 6 PMΦ with protein A stimulation for Lac-PDF, Bic-PDF, and Bic Hi-PDF, respectively (p = 0.14 for LPS, p = 0.14 for protein A) (Figures 1 and 2 ).
DIALYSATE CHEMISTRY
Solute concentrations of sodium, potassium, ionized and total calcium, glucose, pCO 2 , actual bicarbonate, and pH values were not significantly different in the overnight effluents. As expected, after the overnight dwell, glucose had still not equilibrated with the body fluids. Glucose concentration in spent dialysates did not differ significantly between the fluids (370 ± 159, 380 ± 131, and 397 ± 146 mg/dL in Lac-PDF, Bic-PDF, and Bic Hi-PDF effluents, respectively).
DISCUSSION
In the present study, we aimed to assess the ability of PMΦ to generate proinflammatory cytokines following in vivo exposure to lactate-and bicarbonate-buffered dialysis solutions. We chose the overnight dwell to achieve maximal equilibration of the studied dialysis solutions in order to mimic real conditions during CAPD therapy, thus using the full potential of the ex vivo study design implemented. With this approach, we were also able to harvest sufficient numbers of peritoneal cells from each patient in our study protocol; no selection of patients or effluents based on an insufficient cell gain from the peritoneal cavity took place. In contrast to the protocol chosen by Mackenzie et al. (40) , with the overnight test dwell, there was no need to leave the patients with a "dry" abdomen prior to the ex vivo study day in order to maximize peritoneal cell gain.
It was shown earlier by Mackenzie et al. in a similar acute ex vivo experimental setting that significant deterioration of TNFα production after exposure to conventional lactate-based fluids is observed after 30 minutes of intraperitoneal dwell (39) . Under these conditions, significant differences between conventional lactate-based PDF and solutions buffered with pure bicarbonate or a mixture of bicarbonate and lactate were demonstrated, despite the small number of patients taking part in the study (39) . It has also been demonstrated in vitro that only 15 minutes' exposure of peripheral blood monocytes and PMΦ to conventional lactate-buffered dialysate at the original acidic pH resulted in a significant inhibition of TNFα and IL-6 production (41, 42) . This effect was related to the low pH, high lactate effect resulting in cytoplasm acidification (42, 43) . As only partial pH and lactate equilibration takes place after 30 minutes of intraperitoneal dwell, it appears likely that similar pH/ lactate effects may have been responsible for the inhibition of TNFα production observed by Mackenzie et al. in lactate-buffered fluids.
In contrast to this trial design, in the present study we aimed to extend these observations to a more clinically relevant situation with the administration of longer dwell times. As expected, the 8-hour dwell allowed for the complete equilibration of pH, CO 2 , and bicarbonate and lactate concentrations in the PD solutions, yet glucose concentration and related osmolarity were still well above physiological levels. Under these conditions, in contrast to earlier findings by Mackenzie et al. (39, 40) , we did not find significant differences in TNFα or IL-6 generation by peritoneal leukocytes recovered from the overnight effluents. These data demonstrate that any differences observed in cytokine generation between PMΦ exposed in vivo for 30 minutes to bicarbonate-or lactate-buffered dialysis fluids are not sustained following longer dwells. This finding suggests that, in CAPD, exposure of PMΦ to progressively equilibrating dialysis solution allows for at least partial recovery of the impaired cell function resulting from the initial exposure to the low pH and high lactate concentration of the unused dialysate during the first minutes of the dwell. It may also be assumed that, among the population of cells recovered after the 8-hour dwell, a considerable number migrated into the peritoneal cavity after at least partial equilibration had taken place. Thus, these newly immigrated leukocytes have not been exposed to the unequilibrated, low pH dialysis solution, and their potential to produce proinflammatory cytokines has not been compromised.
The results of this study suggest that, in contrast to in vitro and short-dwell ex vivo experiments, during long-term in vivo exposure, the buffer has only a minor influence on cytokine generation by cells migrating into the peritoneal cavity. Whether this finding is true for other cell functions that were shown to be inhibited by the unused acidic dialysis fluids (especially phagocytosis and respiratory burst activation with intracellular killing of bacteria) remains to be established.
It has been shown in previous studies and in this study that, in contrast to lactate and pH, glucose concentration and osmolarity do not reach physiological values, even at the end of an 8-hour dwell with 1.36% glucose fluid (24, 36) . This fact should focus the attention of future long-dwell ex vivo studies on this aspect of dialysis fluid formulation. In this respect, it has been shown by Mackenzie et al. that 30 minutes of in vivo pretreatment with 3.86% glucose fluid resulted in inhibition of TNFα generation compared to low glucose PDF (39) .
It has to be emphasized that the results of this and similar studies represent the effect of a single acute dwell and must be interpreted with caution. To better characterize the biocompatibility profile of new solutions, prospective long-term studies with chronic rather than acute use of the tested fluids are needed. They should allow more relevant assessment of peritoneal host defense mechanisms, together with prospective evaluation of the functional status of the peritoneal membrane. 
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